109 related articles for article (PubMed ID: 21334117)
1. Design, synthesis and cytotoxicity of a new series of isoxazolidines derived from substituted chalcones.
Piotrowska DG; Cieślak M; Królewska K; Wróblewski AE
Eur J Med Chem; 2011 Apr; 46(4):1382-9. PubMed ID: 21334117
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis and cytotoxicity of a new series of isoxazolidine based nucleoside analogues.
Piotrowska DG; Cieślak M; Królewska K; Wróblewski AE
Arch Pharm (Weinheim); 2011 May; 344(5):301-10. PubMed ID: 21312233
[TBL] [Abstract][Full Text] [Related]
3. Novel 5-arylcarbamoyl-2-methylisoxazolidin-3-yl-3-phosphonates as nucleotide analogues.
Kokosza K; Balzarini J; Piotrowska DG
Nucleosides Nucleotides Nucleic Acids; 2014; 33(8):552-82. PubMed ID: 25009989
[TBL] [Abstract][Full Text] [Related]
4. Exploration of the SAR of anti-invasive chalcones: synthesis and biological evaluation of conformationally restricted analogues.
Roman BI; Ryck TD; Dierickx L; Vanhoecke BW; Katritzky AR; Bracke M; Stevens CV
Bioorg Med Chem; 2012 Aug; 20(15):4812-9. PubMed ID: 22743088
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of new 3-(3-phenyl-isoxazol-5-yl) or 3-[(3-phenyl-isoxazol-5-yl)-amino] substituted 4(3H)-quinazolinone derivatives with antineoplastic activity.
Raffa D; Daidone G; Schillaci D; Maggio B; Plescia F
Pharmazie; 1999 Apr; 54(4):251-4. PubMed ID: 10234736
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and cytotoxic activities of 4,5-diarylisoxazoles.
Sun CM; Lin LG; Yu HJ; Cheng CY; Tsai YC; Chu CW; Din YH; Chau YP; Don MJ
Bioorg Med Chem Lett; 2007 Feb; 17(4):1078-81. PubMed ID: 17127061
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and evaluation of novel isoxazolyl chalcones as potential anticancer agents.
Wan M; Xu L; Hua L; Li A; Li S; Lu W; Pang Y; Cao C; Liu X; Jiao P
Bioorg Chem; 2014 Jun; 54():38-43. PubMed ID: 24747188
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of novel isoxazole-based HDAC inhibitors.
Conti P; Tamborini L; Pinto A; Sola L; Ettari R; Mercurio C; De Micheli C
Eur J Med Chem; 2010 Sep; 45(9):4331-8. PubMed ID: 20637529
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, molecular docking and biological evaluation of new dithiocarbamates substituted benzimidazole and chalcones as possible chemotherapeutic agents.
Bacharaju K; Jambula SR; Sivan S; Jyostnatangeda S; Manga V
Bioorg Med Chem Lett; 2012 May; 22(9):3274-7. PubMed ID: 22460028
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biological evaluation of thiophene analogues of chalcones.
Romagnoli R; Baraldi PG; Carrion MD; Cara CL; Cruz-Lopez O; Preti D; Tolomeo M; Grimaudo S; Di Cristina A; Zonta N; Balzarini J; Brancale A; Sarkar T; Hamel E
Bioorg Med Chem; 2008 May; 16(10):5367-76. PubMed ID: 18440234
[TBL] [Abstract][Full Text] [Related]
11. Enantioselective syntheses and cytotoxicity of N,O-nucleosides.
Chiacchio U; Corsaro A; Iannazzo D; Piperno A; Pistarà V; Rescifina A; Romeo R; Valveri V; Mastino A; Romeo G
J Med Chem; 2003 Aug; 46(17):3696-702. PubMed ID: 12904074
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of indolyl chalcones as antitumor agents.
Kumar D; Kumar NM; Akamatsu K; Kusaka E; Harada H; Ito T
Bioorg Med Chem Lett; 2010 Jul; 20(13):3916-9. PubMed ID: 20627724
[TBL] [Abstract][Full Text] [Related]
13. Potent antimitotic and cell growth inhibitory properties of substituted chalcones.
Ducki S; Forrest R; Hadfield JA; Kendall A; Lawrence NJ; McGown AT; Rennison D
Bioorg Med Chem Lett; 1998 May; 8(9):1051-6. PubMed ID: 9871706
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, antiviral, and cytostatic evaluation of novel isoxazolidine analogues of C-nucleotides.
Grabkowska-Drużyc M; Balzarini J; Piotrowska DG
Nucleosides Nucleotides Nucleic Acids; 2013; 32(12):682-99. PubMed ID: 24328565
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological evaluation of 3,4-diaryl-5-aminoisoxazole derivatives.
Liu T; Dong X; Xue N; Wu R; He Q; Yang B; Hu Y
Bioorg Med Chem; 2009 Sep; 17(17):6279-85. PubMed ID: 19665898
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of novel isoxazolines linked via piperazine to 2- benzoisothiazoles as potent apoptotic agents.
Byrappa S; Harsha Raj M; Kungyal T; Kudva N NU; Salimath BP; Lokanatha Rai KM
Eur J Med Chem; 2017 Jan; 126():218-224. PubMed ID: 27821324
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, cytotoxicity, anti-oxidative and anti-inflammatory activity of chalcones and influence of A-ring modifications on the pharmacological effect.
Vogel S; Barbic M; Jürgenliemk G; Heilmann J
Eur J Med Chem; 2010 Jun; 45(6):2206-13. PubMed ID: 20153559
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological evaluation of Mannich bases of heterocyclic chalcone analogs as cytotoxic agents.
Reddy MV; Su CR; Chiou WF; Liu YN; Chen RY; Bastow KF; Lee KH; Wu TS
Bioorg Med Chem; 2008 Aug; 16(15):7358-70. PubMed ID: 18602831
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antiproliferative activity in vitro of new 3-substituted aminoisoxazolo[5,4-b]pyridines.
Poreba K; Wietrzyk J; Opolski A
Acta Pol Pharm; 2003; 60(4):293-301. PubMed ID: 14714858
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and cytotoxicity of O,O'-dialkyl {[2-(substituted phenoxy)acetamido](substituted phenyl)methyl}phosphonates.
Ning L; Wang W; Liang Y; Peng H; Fu L; He H
Eur J Med Chem; 2012 Feb; 48():379-84. PubMed ID: 22200404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
